TY - JOUR AU - Selkoe, D. J. AU - Hardy, J. PY - 2016 DA - 2016// TI - The amyloid hypothesis of Alzheimer’s disease at 25 years JO - EMBO Mol Med VL - 8 UR - https://doi.org/10.15252/emmm.201606210 DO - 10.15252/emmm.201606210 ID - Selkoe2016 ER - TY - JOUR AU - Kummer, M. P. AU - Heneka, M. T. PY - 2014 DA - 2014// TI - Truncated and modified amyloid-beta species JO - Alzheimers Res Ther VL - 6 UR - https://doi.org/10.1186/alzrt258 DO - 10.1186/alzrt258 ID - Kummer2014 ER - TY - STD TI - Andrew RJ, Kellett KA, Thinakaran G, Hooper NM. A Greek Tragedy: the growing complexity of Alzheimer Amyloid precursor protein proteolysis. J Biol Chem. 2016;291(37):19235–44. ID - ref3 ER - TY - JOUR AU - Cescato, R. AU - Dumermuth, E. AU - Spiess, M. AU - Paganetti, P. A. PY - 2000 DA - 2000// TI - Increased generation of alternatively cleaved beta-amyloid peptides in cells expressing mutants of the amyloid precursor protein defective in endocytosis JO - J Neurochem VL - 74 UR - https://doi.org/10.1046/j.1471-4159.2000.741131.x DO - 10.1046/j.1471-4159.2000.741131.x ID - Cescato2000 ER - TY - STD TI - Takeda K, Araki W, Akiyama H, Tabira T. Amino-truncated amyloid β-peptide (A β 5-40/42) produced from caspase-cleaved amyloid precursor protein is deposited in Alzheimer’s disease. FASEB J. 2004;18(14):1755–7. ID - ref5 ER - TY - JOUR AU - Saido, T. C. AU - Yamao-Harigaya, W. AU - Iwatsubo, T. AU - Kawashima, S. PY - 1996 DA - 1996// TI - Amino- and carboxyl-terminal heterogeneity of beta-amyloid peptides deposited in human brain JO - Neurosci Lett VL - 215 UR - https://doi.org/10.1016/0304-3940(96)12970-0 DO - 10.1016/0304-3940(96)12970-0 ID - Saido1996 ER - TY - JOUR AU - He, W. AU - Barrow, C. J. PY - 1999 DA - 1999// TI - The Aβ 3-pyroglutamyl and 11-pyroglutamyl peptides found in senile plaque have greater β-sheet forming and aggregation propensities in vitro than full-length Aβ JO - Biochemistry VL - 38 UR - https://doi.org/10.1021/bi990563r DO - 10.1021/bi990563r ID - He1999 ER - TY - JOUR AU - Schlenzig, D. PY - 2009 DA - 2009// TI - Pyroglutamate formation influences solubility and amyloidogenicity of amyloid peptides JO - Biochemistry VL - 48 UR - https://doi.org/10.1021/bi900818a DO - 10.1021/bi900818a ID - Schlenzig2009 ER - TY - STD TI - Saido TC. Alzheimer’s disease as proteolytic disorders: anabolism and catabolism of beta-amyloid. Neurobiol Aging. 1998;19:S69–75. ID - ref9 ER - TY - JOUR AU - Harigaya, Y. PY - 2000 DA - 2000// TI - Amyloid beta protein starting pyroglutamate at position 3 is a major component of the amyloid deposits in the Alzheimer’s disease brain JO - Biochem Biophys Res Commun VL - 276 UR - https://doi.org/10.1006/bbrc.2000.3490 DO - 10.1006/bbrc.2000.3490 ID - Harigaya2000 ER - TY - JOUR AU - Teng, P. PY - 2015 DA - 2015// TI - HHS public access JO - Gynecol Oncol VL - 136 UR - https://doi.org/10.1016/j.ygyno.2014.12.035 DO - 10.1016/j.ygyno.2014.12.035 ID - Teng2015 ER - TY - STD TI - Mandler M, et al. Pyroglutamylated amyloid-β is associated with hyperphosphorylated tau and severity of Alzheimer’s disease. Acta Neuropathol. 2014;128:67–79. ID - ref12 ER - TY - JOUR AU - Wirths, O. PY - 2009 DA - 2009// TI - Intraneuronal pyroglutamate-Abeta 3–42 triggers neurodegeneration and lethal neurological deficits in a transgenic mouse model JO - Acta Neuropathol VL - 118 UR - https://doi.org/10.1007/s00401-009-0557-5 DO - 10.1007/s00401-009-0557-5 ID - Wirths2009 ER - TY - JOUR AU - Nussbaum, J. M. AU - Seward, M. E. AU - Bloom, G. S. PY - 2013 DA - 2013// TI - Alzheimer disease: a tale of two prions JO - Prion VL - 7 UR - https://doi.org/10.4161/pri.22118 DO - 10.4161/pri.22118 ID - Nussbaum2013 ER - TY - STD TI - Cynis H, Scheel E, Saido TC, Schilling S, Demuth HU. Amyloidogenic processing of amyloid precursor protein: Evidence of a pivotal role of glutaminyl cyclase in generation of pyroglutamate-modified amyloid-β. Biochemistry. 2008;47:7405–13. ID - ref15 ER - TY - JOUR AU - Schilling, S. PY - 2008 DA - 2008// TI - Glutaminyl cyclase inhibition attenuates pyroglutamate Abeta and Alzheimer’s disease-like pathology JO - Nat Med VL - 14 UR - https://doi.org/10.1038/nm.1872 DO - 10.1038/nm.1872 ID - Schilling2008 ER - TY - JOUR AU - Schilling, S. AU - Hoffmann, T. AU - Manhart, S. AU - Hoffmann, M. AU - Demuth, H. U. PY - 2004 DA - 2004// TI - Glutaminyl cyclases unfold glutamyl cyclase activity under mild acid conditions JO - FEBS Lett VL - 563 UR - https://doi.org/10.1016/S0014-5793(04)00300-X DO - 10.1016/S0014-5793(04)00300-X ID - Schilling2004 ER - TY - JOUR AU - Morawski, M. PY - 2014 DA - 2014// TI - Glutaminyl cyclase in human cortex: correlation with (pGlu)-amyloid-β load and cognitive decline in Alzheimer’s disease JO - J Alzheimer’s Dis VL - 39 ID - Morawski2014 ER - TY - JOUR AU - Cynis, H. PY - 2011 DA - 2011// TI - The isoenzyme of glutaminyl cyclase is an important regulator of monocyte infiltration under inflammatory conditions JO - EMBO Mol Med VL - 3 UR - https://doi.org/10.1002/emmm.201100158 DO - 10.1002/emmm.201100158 ID - Cynis2011 ER - TY - JOUR AU - Oliveira, E. B. AU - Gotschlich, E. C. AU - Liu, T. Y. PY - 1979 DA - 1979// TI - Primary structure of human protein JO - J Bol Chem VL - 254 ID - Oliveira1979 ER - TY - JOUR AU - Cynis, H. PY - 2013 DA - 2013// TI - Inhibition of glutaminyl cyclases alleviates CCL2-mediated inflammation of non-alcoholic fatty liver disease in mice JO - Int J Exp Pathol VL - 94 ID - Cynis2013 ER - TY - JOUR AU - Eikelenboom, P. AU - Rozemuller, A. J. AU - Hoozemans, J. J. AU - Veerhuis, R. AU - Gool, W. A. PY - 2000 DA - 2000// TI - Neuroinflammation and Alzheimer disease: clinical and therapeutic implications JO - Alzheimer Dis Assoc Disord VL - 14 UR - https://doi.org/10.1097/00002093-200000001-00009 DO - 10.1097/00002093-200000001-00009 ID - Eikelenboom2000 ER - TY - JOUR AU - Rubio-perez, J. M. AU - Morillas-ruiz, J. M. PY - 2012 DA - 2012// TI - A review: inflammatory process in Alzheimer’s disease, role of cytokines JO - Sci J VL - 2012 ID - Rubio-perez2012 ER - TY - JOUR AU - Heppner, F. L. AU - Ransohoff, R. M. AU - Becher, B. PY - 2015 DA - 2015// TI - Immune attack: the role of inflammation in Alzheimer disease JO - Nat Rev Neurosci VL - 16 UR - https://doi.org/10.1038/nrn3880 DO - 10.1038/nrn3880 ID - Heppner2015 ER - TY - JOUR AU - Kauwe, J. S. K. PY - 2014 DA - 2014// TI - Genome-wide association study of CSF levels of 59 Alzheimer’s disease candidate proteins: significant associations with proteins involved in amyloid processing and inflammation JO - PLoS Genet VL - 10 UR - https://doi.org/10.1371/journal.pgen.1004758 DO - 10.1371/journal.pgen.1004758 ID - Kauwe2014 ER - TY - JOUR AU - Sastre, M. PY - 2003 DA - 2003// TI - Nonsteroidal anti-inflammatory drugs and peroxisome proliferator-activated receptor-gamma agonists modulate immunostimulated processing of amyloid precursor protein through regulation of beta-secretase JO - J Neurosci VL - 23 ID - Sastre2003 ER - TY - JOUR AU - Yan, Q. PY - 2003 DA - 2003// TI - Anti-inflammatory drug therapy alters beta-amyloid processing and deposition in an animal model of Alzheimer’s disease JO - J Neurosci VL - 23 ID - Yan2003 ER - TY - JOUR AU - Lues, I. PY - 2015 DA - 2015// TI - A phase 1 study to evaluate the safety and pharmacokinetics of PQ912, a glutaminyl cyclase inhibitor, in healthy subjects JO - Alzheimers Dement Transl Res Clin Interv VL - 1 UR - https://doi.org/10.1016/j.trci.2015.08.002 DO - 10.1016/j.trci.2015.08.002 ID - Lues2015 ER - TY - JOUR AU - Vagnucci, A. H. AU - Li, W. W. PY - 2003 DA - 2003// TI - Alzheimer’s disease and angiogenesis JO - Lancet VL - 361 UR - https://doi.org/10.1016/S0140-6736(03)12521-4 DO - 10.1016/S0140-6736(03)12521-4 ID - Vagnucci2003 ER - TY - JOUR AU - McKhann, G. M. PY - 2011 DA - 2011// TI - The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease JO - Alzheimers Dement VL - 7 UR - https://doi.org/10.1016/j.jalz.2011.03.005 DO - 10.1016/j.jalz.2011.03.005 ID - McKhann2011 ER - TY - STD TI - Teunissen CE. A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking; Neurology. 2009;73(22):1914–22. ID - ref31 ER - TY - JOUR AU - Schilling, S. PY - 2002 DA - 2002// TI - Continuous spectrometric assays for glutaminyl cyclase activity JO - Anal Biochem VL - 303 UR - https://doi.org/10.1006/abio.2001.5560 DO - 10.1006/abio.2001.5560 ID - Schilling2002 ER - TY - JOUR AU - Lame, M. E. AU - Chambers, E. E. AU - Blatnik, M. PY - 2011 DA - 2011// TI - Quantitation of amyloid beta peptides Aβ(1–38), Aβ(1–40), and Aβ(1–42) in human cerebrospinal fluid by ultra-performance liquid chromatography-tandem mass spectrometry JO - Anal Biochem VL - 419 UR - https://doi.org/10.1016/j.ab.2011.08.010 DO - 10.1016/j.ab.2011.08.010 ID - Lame2011 ER - TY - STD TI - Pannee J, et al. Round robin test on quantification of amyloid-β 1–42 in cerebrospinal fluid by mass spectrometry. Alzheimers Dement. 2016;12:55–9. ID - ref34 ER - TY - STD TI - Kuhlmann J, et al. CSF Aβ1-42 —an excellent but complicated Alzheimer’s biomarker—a route to standardisation. Clin Chim Acta. 2017;467:27–3. ID - ref35 ER - TY - JOUR AU - Kleinschmidt, M. PY - 2015 DA - 2015// TI - Characterizing aging, mild cognitive impairment, and dementia with blood-based biomarkers and neuropsychology JO - J Alzheimers Dis VL - 50 UR - https://doi.org/10.3233/JAD-143189 DO - 10.3233/JAD-143189 ID - Kleinschmidt2015 ER - TY - JOUR AU - Kimpe, L. PY - 2012 DA - 2012// TI - Disturbed Ca2+ homeostasis increases glutaminyl cyclase expression; connecting two early pathogenic events in Alzheimer’s disease in vitro JO - PLoS One VL - 7 UR - https://doi.org/10.1371/journal.pone.0044674 DO - 10.1371/journal.pone.0044674 ID - Kimpe2012 ER - TY - JOUR AU - Valenti, M. T. PY - 2013 DA - 2013// TI - Increased glutaminyl cyclase expression in peripheral blood of Alzheimer’s disease patients JO - J Alzheimers Dis VL - 34 ID - Valenti2013 ER - TY - STD TI - Baldeiras I, et al. Cerebrospinal fluid Aβ40 is similarly reduced in patients with frontotemporal lobar degeneration and Alzheimer’s disease. J Neurol Sci. 2015;358:308–16. ID - ref39 ER - TY - JOUR AU - Dorey, A. AU - Perret-Liaudet, A. AU - Tholance, Y. AU - Fourier, A. AU - Quadrio, I. PY - 2015 DA - 2015// TI - Cerebrospinal fluid Aβ40 improves the interpretation of Aβ42 concentration for diagnosing Alzheimer’s disease JO - Front Neurol VL - 6 UR - https://doi.org/10.3389/fneur.2015.00247 DO - 10.3389/fneur.2015.00247 ID - Dorey2015 ER - TY - STD TI - Lewczuk P, et al. Cerebrospinal fluid Aβ42/40 corresponds better than Aβ42 to amyloid PET in Alzheimer’s disease.  J Alzheimers Dis. 2017;55(2):813–22. ID - ref41 ER - TY - JOUR AU - Lewczuk, P. PY - 2004 DA - 2004// TI - Neurochemical diagnosis of Alzheimer’s dementia by CSF Aβ42, Aβ42/Aβ40 ratio and total tau JO - Neurobiol Aging VL - 25 UR - https://doi.org/10.1016/S0197-4580(03)00086-1 DO - 10.1016/S0197-4580(03)00086-1 ID - Lewczuk2004 ER - TY - JOUR AU - Janelidze, S. PY - 2016 DA - 2016// TI - CSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios: better diagnostic markers of Alzheimer disease JO - Ann Clin Transl Neurol VL - 3 UR - https://doi.org/10.1002/acn3.274 DO - 10.1002/acn3.274 ID - Janelidze2016 ER - TY - JOUR AU - Kim, H. J. PY - 2015 DA - 2015// TI - Elevation of the plasma Aβ40-Aβ42 ratio as a diagnostic marker of sporadic early-onset Alzheimer’s disease JO - J Alzheimers Dis VL - 48 UR - https://doi.org/10.3233/JAD-143018 DO - 10.3233/JAD-143018 ID - Kim2015 ER - TY - JOUR AU - Blennow, K. PY - 2009 DA - 2009// TI - Evolution of Abeta42 and Abeta40 levels and Abeta42-Abeta40 ratio in plasma during progression of Alzheimer’s disease, a multicenter assessment JO - J Nutr Health Aging VL - 13 UR - https://doi.org/10.1007/s12603-009-0059-0 DO - 10.1007/s12603-009-0059-0 ID - Blennow2009 ER - TY - JOUR AU - Abraham, J. -. D. PY - 2013 DA - 2013// TI - Cerebrospinal Aβ11-x and 17-x levels as indicators of mild cognitive impairment and patients’ stratification in Alzheimer's disease JO - Transl Psychiatry VL - 3 UR - https://doi.org/10.1038/tp.2013.58 DO - 10.1038/tp.2013.58 ID - Abraham2013 ER - TY - JOUR AU - Bo, R. AU - Ghezzi, S. AU - Scarpini, E. AU - Bresolin, N. AU - Comi, G. P. PY - 2009 DA - 2009// TI - VEGF genetic variability is associated with increased risk of developing Alzheimer’s disease JO - J Neurol Sci VL - 283 UR - https://doi.org/10.1016/j.jns.2009.02.318 DO - 10.1016/j.jns.2009.02.318 ID - Bo2009 ER - TY - JOUR AU - Chiappelli, M. PY - 2006 DA - 2006// TI - VEGF gene and phenotype relation with Alzheimer’s disease and mild cognitive impairment JO - Rejuvenation Res VL - 9 UR - https://doi.org/10.1089/rej.2006.9.485 DO - 10.1089/rej.2006.9.485 ID - Chiappelli2006 ER - TY - STD TI - Patel NS, et al. Alzheimer’s β-amyloid peptide blocks vascular endothelial growth factor mediated signaling via direct interaction with VEGFR-2. J Neurochem. 2010;112:66–76. ID - ref49 ER - TY - JOUR AU - Religa, P. PY - 2013 DA - 2013// TI - VEGF significantly restores impaired memory behavior in Alzheimer’s mice by improvement of vascular survival JO - Sci Rep VL - 3 UR - https://doi.org/10.1038/srep02053 DO - 10.1038/srep02053 ID - Religa2013 ER - TY - JOUR AU - Wang, P. PY - 2011 DA - 2011// TI - VEGF-induced angiogenesis ameliorates the memory impairment in APP transgenic mouse model of Alzheimer’s disease JO - Biochem Biophys Res Commun VL - 411 UR - https://doi.org/10.1016/j.bbrc.2011.07.003 DO - 10.1016/j.bbrc.2011.07.003 ID - Wang2011 ER - TY - JOUR AU - Herran, E. PY - 2015 DA - 2015// TI - Enhanced hippocampal neurogenesis in APP-Ps1 mouse model of Alzheimer’s disease after implantation of VEGF-loaded PLGA nanospheres JO - Curr Alzheimer Res VL - 12 UR - https://doi.org/10.2174/1567205012666151027121622 DO - 10.2174/1567205012666151027121622 ID - Herran2015 ER - TY - JOUR AU - Yu, S. PY - 2016 DA - 2016// TI - Diagnostic utility of VEGF and soluble CD40L levels in serum of Alzheimer’s patients JO - Clin Chim Acta VL - 453 UR - https://doi.org/10.1016/j.cca.2015.12.018 DO - 10.1016/j.cca.2015.12.018 ID - Yu2016 ER - TY - STD TI - Huang L, Jia J, Liu R. Decreased serum levels of the angiogenic factors VEGF and TGF-β1 in Alzheimer’s disease and amnestic mild cognitive impairment. Neurosci Lett. 2013;550:60–3. ID - ref54 ER - TY - JOUR AU - Mateo, I. PY - 2007 DA - 2007// TI - Low serum VEGF levels are associated with Alzheimer’s disease JO - Acta Neurol Scand VL - 116 UR - https://doi.org/10.1111/j.1600-0404.2006.00775.x DO - 10.1111/j.1600-0404.2006.00775.x ID - Mateo2007 ER - TY - JOUR AU - Tarkowski, E. PY - 2002 DA - 2002// TI - Increased intrathecal levels of the angiogenic factors VEGF and TGF-beta in Alzheimer’s disease and vascular dementia JO - Neurobiol Aging VL - 23 UR - https://doi.org/10.1016/S0197-4580(01)00285-8 DO - 10.1016/S0197-4580(01)00285-8 ID - Tarkowski2002 ER -